Erica Rogers Joins Axena Health’s Board of Directors

Axena Health Inc. has appointed Erica Rogers to its Board of Directors. Known for her transformative leadership in the medical device industry, Rogers brings more than two decades of expertise, including her tenure as president and CEO of Silk Road Medical, where she guided the company from early stages through its initial public offering and commercial expansion, pioneering advancements in stroke prevention.

Roger’s experience leading strong organic growth and operational excellence within commercial-stage medical device businesses aligns well with Axena Health’s commitment to addressing the needs of women with pelvic health disorders. At Silk Road Medical, she led innovations in minimally invasive technologies, revolutionizing treatment pathways for vascular care and setting new standards in clinical outcomes. Her background in commercial execution, strategic planning, regulatory affairs and reimbursement align well with Axena Health as it strives to improve female pelvic health care.

“We are thrilled to welcome Erica to our Board of Directors,” Axena Health CEO Randy Pritchard said. “Her impressive experience in advancing medical devices from concept to widespread adoption will be critical as we expand the business. Erica’s leadership will help guide us as we provide accessible, clinically proven treatments that provide improved outcomes and greater access to care.”

The Leva Pelvic Health System offers a non-invasive, medication-free way for women to train and strengthen their pelvic floor muscles—at home in just five minutes a day—to treat urinary incontinence (UI) and chronic fecal incontinence (FI). Combining a small U.S. Food and Drug Administration-cleared vaginal motion sensor with integrated software, the Leva System offers precise visualization of pelvic movement in real-time, enables progress tracking and allows active physician involvement, all of which support women’s success. Recognizing that level-one evidence shows pelvic floor muscle training is most effective when performed under the supervision of a skilled healthcare provider, the Leva System is available by prescription only, allowing physicians the opportunity to treat UI and chronic FI on a broad scale and with continued involvement in patient success. The Leva System has multiple clinical trials and published data from globally recognized medical centers supporting its efficacy in treating UI, including two studies in Obstetrics and Gynecology (The Green Journal), the official publication of the American College of Obstetricians and Gynecologists (ACOG).

“I’ve followed the female pelvic health space for years and am excited to join Axena Health because of its unwavering dedication to redefining what’s possible through evidence-based innovation,” Rogers stated. “It’s rare to see such a robust commitment to both patient needs and rigorous clinical data, and I look forward to contributing to a future where Axena’s Leva Pelvic Health System can provide improved care and quality of life for women everywhere.”

Axena Health Inc. is dedicated to improving the lives of women with pelvic floor disorders. Axena Health’s flagship product, the Leva Pelvic Health System, offers a novel, effective, first-line treatment for urinary incontinence (UI) and chronic fecal incontinence (FI), underreported conditions affecting more than 78 million worldwide and 12 million U.S. women. Axena Health’s technology enables non-invasive, drug-free treatment through precise visualization of movement in real time during pelvic floor muscle training, while monitoring usage and progress.